Evidence map›Paper›PMID 42737791›Full record

ReviewInternational journal of molecular sciences2026

Plant-Mediated Production of Antibacterial Nanomaterials Fulfilling a Reactive Oxygen Species Strategy.

Olga Tsivileva

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Olga TsivilevaInstitute of Biochemistry and Physiology of Plants and Microorganisms, Saratov Scientific Centre of the Russian Academy of Sciences, Saratov 410049, Russia.ORCID 0000-0002-5269-349X

Funding

Ministry of Science and Higher Education of the Russian Federation at the FRC Saratov Scientific Centre of the RAS NO
6 · The paper itself

Abstract

Innovative antibacterial agents, which need to be urgently developed, should provide a new path that avoids pathogenic bacteria drug resistance. A promising strategy to treat bacterial infections consists of implementing nanoparticles (NPs). Several nanomaterials, including metal NPs, induce oxidative stress in living cells by producing reactive radicals at their surface. The oxidative stress thus raised is a potent mechanism of antibacterial action. Owing to their reactive oxygen species (ROS)-related ability, metal NPs could contribute to the targeted bioactivity of preparations designed on their basis. However, totally inorganic nanomaterials frequently suffer from relatively low selectivity with respect to bacterial targets, limited dispersibility, and undesirable side effects linked to ambiguous toxicity. For the development of bacteria drug resistance, the incorporation of specific ligands responsible for bacterial eradication into NPs seems to be necessary. The synergistic action of NPs with natural materials demonstrates complementary effects and improved antibacterial capacity. The modification of NPs by natural organic supporting agents extracted from plants could potentially resolve some of the existing issues related to bacterial drug resistance. The purpose of the current work is to review the ROS-mediated antibacterial manifestation strategy of metal NPs conjugated with botanical bactericidal substances. Different aspects of the metal toxicity of NPs and the compromised selectivity of ROS for bacterial pathogens are also considered.

Indexed as

Anti-Bacterial AgentsMetal NanoparticlesNanostructuresPlantsReactive Oxygen SpeciesBacteriaHumansOxidative StressPlant ExtractsAnti-Bacterial AgentsPlant ExtractsReactive Oxygen Speciesantibacterial action mechanismantimicrobial activityherbal extractmetal nanoparticlesnanomaterialspathogenic bacteriaphytochemicalphytosynthesisROS

Identifiers

PMID42737791
PMCPMC13566224

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.